NAEPP Committee Webinar
National Heart, Lung, and Blood Institute

The National Asthma Education and Prevention Program (NAEPP) convened on Thursday, December 14, via webinar. The meeting was open to the public. Dr. James P. Kiley, Director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute (NHLBI), presided as Executive Secretary.

National Institutes of Health

National Heart, Lung, Blood Institute

NAEPP Committee Webinar

December 14, 2017

10:00 a.m.- 12:00 p.m. ET

The National Asthma Education and Prevention Program (NAEPP) convened on Thursday, December 14, via webinar. The meeting was open to the public. Dr. James P. Kiley, Director of the Division of Lung Diseases at the National Heart, Lung, and Blood Institute (NHLBI), presided as Executive Secretary.

Committee Members attending via teleconference

Dr. Robert F. Lemanske

Dr. Joseph Kofi Berko

Ms. Sheila Brown

Dr. Kurtis S. Elward

Dr. Anne Mentro Fitzpatrick

Dr. Lynn B Gerald

Dr. Joy Hsu

Dr. Elliot Israel

Dr. Monica Kraft

Ms. Lynda Mitchell

Dr. Giselle S. Mosnaim

Dr. Gary S. Rachelefsky

Dr. Lisa M. Wheatley

Dr. Juan P. Wisnivesky

Dr. Darryl C. Zeldin

Other Attendees

Alice Harrington, Susan Ross, Nick Hanania, Michael Schatz, Michael Hagen, Debra Long, Don Uden, Cathy Bailey, John Mitchell, Bill Storms, Elizabeth Herman, Isaretta L. Riley

NIH/NHLBI employees attending

A number of NHLBI staff members were in attendance.


I. Welcome, James P. Kiley, PhD

Dr. Kiley, Executive Secretary of the NAEPP Committee, welcomed the committee and other participants to the meeting. Rob Lemanske was introduced as the chair. NAEPP Committee consists of 15 members include: five government employees, five federal members, and five member organization representatives. The Committee is a Federal Advisory Committee Act (FACA) committee. Members representing organizations were named by their organizations. The core committee allows NHLBI to adhere to the FACA guidelines.

II. Introduction of Committee, Robert F. Lemanske, Jr, MD

Dr. Lemanske introduced the fifteen committee members and the members provided a brief introduction of themselves.

III. Review of the Committee’s Charge, Dr. Kiley and Committee

Dr. Kiley presented the mission of the FACA. He shared that the special government employees went through a vetting process. The previous NAEPP membership was open and did not include an in-depth vetting process. The Primary mission of the Committee is to advice NHLBI and other federal agencies and the secondary mission was presented. Other partners include NIH Institutes, HUD, EPA, CDC and other agencies involved in asthma work.

Description of the history of the NAEPP was presented. Original NAEPP Design and Framework was presented. The program was designed to translate knowledge and the research so that it could be used by the public. The committee has been transformed with the core being the NAEPP committee and establish working groups around the committee. The Expert Panel working group has already been established. The previous review of the 2007 guidelines was made to determine if the update was needed. Unification for coordinated delivery of information and updates.

IV. Committee operations and updates, Janet de Jesus, MS, RD

Ms. de Jesus provided a brief overview of Committee operations. The Committee includes 15 voting members and Dr. Kiley (Executive Secretary) will be copied on all correspondence. All Committee meetings will be open to public. Notifications of future meetings will be posted in the Federal Register and on the NHLBI website.

Workgroups such as the future Expert Panel Working Group will not meet publicly but meetings. Workgroup will present to the NAEPP Committee in public meetings. Historical NAEPP working groups were discussed in context of possible new workgroups.

The Expert Panel Working group will be charged with updating key topics from EPR-3. The working group will include some members from the NAEPP Committee to provide cross over. The roster has not been finalized. There was a call for nominations via public notice. A logistics and methodology contractor will provide support to the Expert Panel Working Group.

Committee Members discussed possible workgroups such on topics such as: school education, dissemination and implementation (resources, EMRs), patient advocacy/advisory, and health policy. The environmental aspects of asthma will be included in the updated guidelines. The Asthma Disparities Working Group (ADWG) is internal to government partners. The ADWG can provide updates to the Committee. An Implementation 3

An update on the asthma AHRQ systematic reviews was provided. The systematic reviews are complete and pending co-publications with journals.

V. Next steps and committee discussion, Dr. Kiley and Dr. Lemanske

NHLBI will begin the process for convening the Expert Panel Working Group and will seek contractor support. The Committee is chartered to have two meetings per year and we will plan an in person meeting this year.

VI. Committee discussion and Public Q&A, All

The committee discussed the topics of social determinants of health and possible revision of medications in the updated guideline. The social determinants of health were not selected for an evidence review topic. Pharmacotherapy questions are included in a review that will inform the updates.

  • Additional workgroup groups were suggested on subpopulations of asthma and emergency medical providers.
  • The issue of bringing forward content from EPR-3 was discussed. Currently the focus of the Guideline update will be on updating the topics in the new evidence reviews. The Expert Panel will discuss how if content from EPR-3 should be included in the new report.
  • Other deliverables such as toolkits and materials that can be used for education and resources would be a great contribution from NAEPP partners.

The meeting was adjourned at noon.